2[1]Memezawa H,Simith ML,Siesjo BK. Penumbral tissue salvaged dy reperfusion following middle cerebral artery occlusion in rates. Stroke, 1992,23 (4) : 552 ～ 559
3[2]OvtFgaara K,Sereghy T,Pederson H,et al. Effect of delayed thrombolysis Whth rt-PA in a ral embolic stroke model. J Cereb Blood Flow Metab,1994,14(3) :472～477
4[3]Sakurama T, Kitamura R, Kaneko M, et al. Tissue-typa Plasminogen activator improves neurological functions in a rat model of thromboembolic stroke. Stroke,1994,25(2):451～456
5[4]Gross CE,Raymond SJ,Howard DB,et al. Delayed tissueplasminogen activator therapy in a rabbit model of thromboembolic stroke.Neurosurgery,1995,36(6):1172～1177
6[6]Adeams HP Jr,Brott TG,Furlan AJ, et a. GUidelines for thrombolytic therapy for acute stroke: a supplement to thegUidelines for the management of patients with acute ischemic stroke. Stroke, 1996,27(9): 1711～1718
7[11]Hack W. Intensiv care in acute stroke. Ceredrovase Dis,1997,(3) :18～23
10Hacke W,Bluhmki E,Steiner T,et al.Dichotomized efficacy end points and global end-point analysis applied to the ECASS in tention-totreat data set.Post hoc analysis of ECASS Ⅰ[].Stroke.1998
